Septerna, Inc. (SEPN)
(Delayed Data from NSDQ)
$11.75 USD
+0.10 (0.86%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $11.76 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SEPN 11.75 +0.10(0.86%)
Will SEPN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SEPN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SEPN
Does Septerna, Inc. (SEPN) Have the Potential to Rally 151.27% as Wall Street Analysts Expect?
ETFs to Capitalize on the Novo Nordisk-Septerna Deal
SEPN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk
Wall Street Analysts Predict a 207.31% Upside in Septerna, Inc. (SEPN): Here's What You Should Know
Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News
Other News for SEPN
Septerna (SEPN) Receives Buy Rating with Promising Outlook | SEPN Stock News
Septerna initiated with a Buy at H.C. Wainwright
This Ventas Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
This Hilton Worldwide Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
The Analyst Verdict: Septerna In The Eyes Of 4 Experts